top of page


Dr. M. Rasool CUK conference .tif


DST SERB (2018 -2021)
(Sanctioned amount - 36,32,000 INR)

Unravelling the molecular basis of cyanidin, a natural flavonoid in IL-17 mediated signaling and Th17 and Treg cell axis in rheumatoid arthritis pathogenesis .


DST SERB (2014 -2017)
(Sanctioned amount  - 33,59,000 INR)

Inhibition of intracellular signaling pathways and pro-inflammatory cytokines as a possible target for the treatment of rheumatoid arthritis by p-coumaric acid, a common dietary polyphenol - an experimental study .


DBT (2018 -2021)
(Sanctioned amount - 59,99,000  INR)

Potent and selective PDE4B inhibitors for the potential treatment of arthritis (In collaboration with Dr. Reddy's Institute of Life Sciences, Hyderabad) .


AYUSH (2018 -2021)
(Sanctioned amount - 33,70,000 INR)

Exploring the therapeutic mechanism of Majoon Chobchini, an unani medicine in the management of rheumatoid arthritis (Waja - ul- mafasil) - an immunological investigation.


AYUSH (2014 -2017)
(Sanctioned amount - 19,23,600  INR)

Efficacy of Majoon Ushba, an unani formulation with reference to biochemical and immunological parameters in the management of rheumatoid arthritis (Waja - ul- mafasil) - an experimental study  .


ICMR (2012 -2015)
( Sanctioned amount - 11,30,000  INR)

A study on in-vitro anti-inflammatory effect of Indian ayurvedic herbal formulation "Triphala" and its mechanism of action.


DBT - NANO PLATFORM (2014 -2017)
(Sanctioned amount - 30,17,000 INR)

Investigating the delivery of withaferin - A, a steroidal lactone and dexamethasone palmitate using mannosylated liposomes to macrophages in-vitro and during experimental arthritis for its effective anti-inflammatory action.


bottom of page